[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients
BJU International, 04/24/2012
Clinical Article
Poulsen MH et al. – Due to a relatively low sensitivity and a correspondingly rather low positive predictive values (PPV), fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) is not ideal for primary lymph node staging in patients with prostate cancer. However, FCH PET/CT does convey important additional information otherwise not recognised, especially for bone metastases.

![print MDLinx article: [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients print mdlinx article: [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients](/img/articles-print-off.png)
![email MDLinx article: [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients email mdlinx article: [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients](/img/articles-email-off.png)
![save MDLinx article to My Library: [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients save mdlinx article to my library: [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients](/img/articles-save-to-my-library-off.png)